Alternative mRNA modification lets ribosomes move nearly twice as fast
In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to help deliver next-generation mRNA therapeutics, including vaccines to fight infectious diseases, cancer and autoimmune conditions, faster and more efficiently than the industry standard.
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
Good news deserves a clean reading experience. AdGuard blocks ads, trackers, and malware across all your devices so you can focus on what matters.
Try AdGuard →
The Passivhaus standard is growing in popularity as UK homeowners adapt to hotter summer temperatures.
Three scientists beat J&J's defamation suit over talc research Reuters
OpenAI cuts developer pricing for frontier GPT-5.6 Sol model by more than 20% Reuters
Google's latest AI breakthrough may turn your Pixel phone into a medical lab PhoneArena
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →